Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the independent and synergistic effects of amyloid and small vessel disease (SVD) burden on longitudinal cognitive decline in patients with subcortical vascular dementia (SVaD). METHODS: A longitudinal cohort study was conducted involving patients from outpatient clinics of 2 tertiary referral centers. Sixty-one patients with SVaD were prospectively recruited and underwent MRI, 11C-Pittsburgh compound B (PiB) PET at baseline, and a 3-year annual neuropsychological follow-up. Effects of PiB positivity and SVD markers (white matter hyperintensities [WMH], lacunes, and microbleeds) on longitudinal cognitive decline were evaluated using generalized estimation equation after controlling for age, sex, education, APOE4 allele, and follow-up interval. RESULTS: When individual neuropsychological tests were used as outcome measures, PiB positivity was associated with faster cognitive decline in attention, visuospatial, visual memory, and global cognition function. Higher WMH burden was associated with faster cognitive decline in attention, visuospatial, visual recognition memory, and semantic/phonemic fluency function, whereas lacunes and microbleeds had no significant effects. When global dementia rating (Clinical Dementia Rating sum of boxes) was considered as an outcome measure, however, only PiB positivity was associated with faster cognitive decline. Significant interactions between PiB positivity and higher SVD burden were found to affect cognitive decline in semantic word fluency (from WMH burden) and global dementia rating (from microbleed burden). CONCLUSIONS: In SVaD patients, amyloid burden, independently or interactively with SVD, contributed to longitudinal cognitive decline. Amyloid deposition was the strongest poor prognostic factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, AD pathology increases the risk of dementia after stroke 103 and contributes to cognitive decline in patients with VCI. 104”
From Vascular Cognitive Impairment (2017) · cites this paper as [104]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
Mc Causland, F. R., Brunelli, S. M., & Waikar, S. S. (2013) · American Journal of Nephrology · doi:10.1159/000355958 · Cited by 2,690
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Subcortical ischaemic vascular dementia
Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00190-4 · Cited by 1,067
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997) · PubMed · Cited by 846
Research criteria for subcortical vascular dementia in clinical trials
Erkinjuntti, T., Inzitari, D., Pantoni, L., Wallin, A., Scheltens, P., Rockwood, K., Roman, G. C., Chui, H., & Desmond, D. W. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_4 · Cited by 631
Ahn, H.-J., Chin, J., Park, A., Lee, B. H., Suh, M. K., Seo, S. W., & Na, D. L. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.7.1071 · Cited by 486
Self-citationClinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series
Lim, A., Tsuang, D., Kukull, W., Nochlin, D., Leverenz, J., McCormick, W., Bowen, J., Teri, L., Thompson, J., Peskind, E. R., et al. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb02571.x · Cited by 451
Research works printed but not linked: 1
- Kang Y, Na DL. Seoul Neuropsychological Screening Battery: Professional Manual. Seoul: Human Brain Research & Consulting Co.; 2003.
Cited by
Post-Stroke Cognitive Impairment and Dementia
Rost, N. S., Brodtmann, A., Pase, M. P., van Veluw, S. J., Biffi, A., Duering, M., Hinman, J. D., & Dichgans, M. (2022) · Circulation Research · doi:10.1161/circresaha.122.319951 · Cited by 790
Dichgans, M., & Leys, D. (2017) · Circulation Research · doi:10.1161/circresaha.116.308426 · Cited by 581
“However, there are few specific data for VCI.11 Physical activity has beneficial effects on synaptogenesis, neurogenesis, and vascular health and might, therefore, reduce the risk of cognitive impairment.”
BackgroundInfluentialClinical presentations and epidemiology of vascular dementia
Smith, E. E. (2017) · Clinical Science · doi:10.1042/cs20160607 · Cited by 249
Neuroinflammation as a Key Driver of Secondary Neurodegeneration Following Stroke?
Stuckey, S. M., Ong, L. K., Collins‐Praino, L. E., & Turner, R. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313101 · Cited by 170
“As such, various VaD studies have demonstrated that increased levels of Aβ deposition and cerebral amyloid angiopathy [269,271,272].”
BackgroundCognitive impairment and stroke in elderly patients
Corrao, S., Lo Coco, D., & Lopez, G. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s75306 · Cited by 158
“48 Many epidemiological studies also lend support to the concept that stroke and dementia are interrelated.”
Metadata
- Authors
- Ye, B. S., Seo, S. W., Kim, J.-H., Kim, G. H., Cho, H., Noh, Y., Kim, H. J., Yoon, C. W., Woo, S.-Y., Kim, S. H., Park, H. K., Kim, S. T., Choe, Y. S., Lee, K. H., Kim, J. S., Oh, S. J., Kim, C., Weiner, M., Lee, J.-H., & Na, D. L.
- Affiliations
- Ewha Womans University (KR)
- Corresponding author
- Na, Duk L.
- ORCID
- Venue
- Neurology
- Published
- 2015-11-10
- Volume
- 85
- Issue
- 19
- Pages
- 1687-1693
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC4653105
- OpenAlex
- W2329619526
- Cited by
- 67
- References
- 29
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 9 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 8 · 2016: 5
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- subcortical vascular dementia, cognitive decline, amyloid burden, cerebral small vessel disease, white matter hyperintensities, lacunes, microbleeds, APOE ε4, semantic fluency, Clinical Dementia Rating, prognostic factors
- MeSH terms
- Aged, Aged, 80 and over, Amyloid, Cognition Disorders, Female, Follow-Up Studies, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Dementia, Vascular, Cohort Studies, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia. https://app.cochat.ai/papers/10.1212/wnl.0000000000002097
- The paper
- Ye, B. S., Seo, S. W., Kim, J.-H., Kim, G. H., Cho, H., Noh, Y., Kim, H. J., Yoon, C. W., Woo, S.-Y., Kim, S. H., Park, H. K., Kim, S. T., Choe, Y. S., Lee, K. H., Kim, J. S., Oh, S. J., Kim, C., Weiner, M., Lee, J.-H., & Na, D. L. (2015). Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia. Neurology. https://doi.org/10.1212/wnl.0000000000002097
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.